Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 121

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 121
---
 with respect to such new Superior Proposal from the Company.           |

| (e) | The Board shall promptly reaffirm the Board Recommendation by press release after any Acquisition Proposal                                                                                   
 which is not determined to be a Superior Proposal is publicly announced or publicly disclosed or the Board determines that a proposed amendment to the terms of the Agreement or the Plan of |

72

| Arrangement as contemplated under the Agreement would result in an Acquisition Proposal no longer being a Superior Proposal. The Company shall provide the Purchaser and its outside legal counsel                 
 with a reasonable opportunity to review the form and content of any such press release and shall make all reasonable amendments to such press release as requested by the Purchaser and its outside legal counsel. |

| (f) | If the Special Meeting is to be held during a Right to Match Period, the Company may, and shall at the request                                                                                                                                
 of the Purchaser, postpone or adjourn the Special Meeting to a date that is not more than fifteen (15) days after the scheduled date of the Special Meeting, but in any event to a date that is not less than five (5) Business Days prior to 
 the Outside Date.                                                                                                                                                                                                                             |

| (g) | Nothing contained in the non-solicitation terms of the Agreement shall                                                       
 limit in any way the obligation of the Company to convene and hold the Special Meeting while the Agreement remains in force. |

| (h) | Nothing in the Agreement shall prevent the Board or the Company from responding through a directors’                                                                                                                                                    
 circular or otherwise as required by applicable Laws to an Acquisition Proposal where such response is not an acceptance, approval, endorsement or recommendation of such Acquisition Proposal and does not otherwise constitute a Change of            
 Recommendation; provided, that the Company shall provide the Purchaser and its outside legal counsel with a reasonable opportunity to review the form and content of such circular or other disclosure and shall make all reasonable amendments to such 
 circular or other disclosure as requested by the Purchaser and its outside legal counsel.                                                                                                                                                               |

| (i) | Nothing in the non-solicitation obligations under the Agreement or the                                                                                                                                                                                    
 determination by the Board of Directors of a Superior Proposal shall require the sharing with the Purchaser of any information considered by external legal counsel of each of the Company and the Purchaser to be competitively sensitive information in 
 connection with competition compliance principles, which competitively sensitive information will be provided only to the external legal counsel or external expert of the Purchaser and shall not be shared by such legal counsel or expert with any     
 other